Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.

An open study of long term treatment with an oral beta 2 agonist (pirbuterol 20 mg three times daily) was undertaken in 63 patients with severe chronic heart failure. During three months of treatment 20 (32%) patients died, of whom 16 were taking the drug at the time of death. Mortality was related...

Celý popis

Podrobná bibliografie

Vydáno v:	Br Heart J
Hlavní autoři:	Dawson, J R, Canepa-Anson, R, Kuan, P, Reuben, S R, Poole-Wilson, P A, Sutton, G C
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1983
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481410/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6137226/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.50.3.282
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!